CVS shareholders approve 33.5M share increase to equity plan; all directors elected

CVS HEALTH Corp

Shareholders approved amendment to 2017 ICP, increasing authorized shares by 33.5 million for future awards.
All 12 director nominees elected, including CEO Karen S. Lynch, with >85% support from votes cast.
Advisory vote on named executive officer compensation passed (818M for, 139M against, excluding broker non-votes).
Ratification of Ernst & Young as independent auditor for 2024 approved (1.083B for, 22.9M against).
Four stockholder proposals (worker rights, majority vote, golden parachute, director time disclosure) all rejected.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.